(2021). New Studies Reveal Potential Mechanisms of Resistance to CDK4/6 Inhibitors in HR+/HER2– Breast Cancer. Oncologist.
Citación estilo Chicago"New Studies Reveal Potential Mechanisms of Resistance to CDK4/6 Inhibitors in HR+/HER2– Breast Cancer." Oncologist 2021.
Cita MLA"New Studies Reveal Potential Mechanisms of Resistance to CDK4/6 Inhibitors in HR+/HER2– Breast Cancer." Oncologist 2021.
Precaución: Estas citas no son 100% exactas.